View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
May 2021
News | Clinical knowledge summaries | Into practice | Announcements | Events | Blogs | Get involved


an ampoule of Spinraza shown to us by a practitioner

Thousands to benefit from new treatment for high cholesterol

Around 70,000 adults in England with primary hypercholesterolaemia or mixed dyslipidaemia, also known as high cholesterol, will now be eligible for treatment with bempedoic acid with ezetimibe. Our new guidance recommends this as a treatment option for people who are unable to use statins and whose high cholesterol is not well-controlled with ezetimibe alone.

More people to benefit from nusinersen for spinal muscular atrophy following review

We’ve extended the clinical eligibility criteria for nusinersen for spinal muscular atrophy (SMA).
Type III SMA patients who are not able to walk are now eligible for this treatment. This follows a review of data collected as part of a managed access agreement between NHS England and NHS Improvement, and Biogen.

Catch up on all our latest news articles

Clinical knowledge summaries

New clinical knowledge summary (CKS) topics and updates on the site from the start of May include:

  • Chronic pain, a new topic based on our Chronic pain (primary and secondary) in over 16s guideline.
  • Our 'Hypertension - not diabetic' topic has been renamed 'Hypertension'.
  • Our 'Immunisations – pneumococcal' topic has been aligned with Public Health England's Immunisation against infectious disease green book chapter 25: Pneumococcal. The alignment also includes minor structural changes.
Our CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover 1,000 clinical presentations or patient scenarios, free to access in the UK.

Into practice

Developing a clinical framework for dementia, delirium and depression

Leeds Community Healthcare NHS Trust developed a clinical framework that brings together recommendations from 6 NICE guidelines. It provides frontline clinicians with standards for care delivery and outlines practical steps to ensure person-centred care.
To support implementation of the framework, the team provided frontline clinical staff with prompt cards. These act as a reference aid for how to embed the clinical framework in day-to-day care delivery. A 1-day training session also enabled clinicians to better understand:

  • the rationale for the framework
  • why person-centred care makes such a difference to people living with dementia, delirium and depression.

The project enabled teams to identify key risks, signs and symptoms associated with all 3 conditions in an effective and timely manner. Longer-term, this will enable signs of delirium to be identified earlier for treatment in community settings rather than hospital admission.

This project is one of many implementation case studies contained in our shared learning collection.

Read the clinical framework case study
generic cover of the impact report series with the title and abstract connections graphic

Impact report on diagnostic pathology published 

The report explores how NICE’s evidence-based guidance contributes to improvements in diagnostic pathology, as well as highlighting where progress still needs to be made.

Read the NICE impact report on diagnostic pathology


NICE and CQC release updated joint working agreement

We’ve published an updated memorandum of understanding agreement with the Care Quality Commission (CQC). The agreement describes how both organisations will work together, in a coordinated way, to inform and accelerate improvements in the quality and safety of care.

NICE joins forces with partners to found the GetReal Institute

The GetReal Institute’s core mission is to facilitate the adoption and implementation of real-world evidence in healthcare decision-making across Europe. This aligns with our ambition set out in our 5-year strategy, to play a leadership role in data, research and science.

NICE will join 9 other organisations pending finalisation and execution of the membership agreement:

  • Clinical Practice Research Datalink
  • Eli Lilly and Company
  • Hoffmann-La Roche
  • GlaxoSmithKline
  • International Alliance of Patients’ Organizations
  • Janssen, Pharmaceutical Companies of Johnson & Johnson
  • Norwegian Medicines Agency
  • University Medical Center Utrecht.
  • University Medical Center Utrecht (UMCU).


Branded generic graphic with the details of the HTAi 2021 virtual meeting

Join us for HTAi 2021 virtual annual meeting

We will be co-hosting the Health Technology Assessment international’s (HTAi) annual meeting on:

  • Saturday 19 to Wednesday 23 June 2021.

This year, the main theme of the meeting is ‘Innovation through health technology assessment (HTA)’. NICE is taking part in various sessions including panels on ‘the importance of regulatory science in HTA’ and ‘keeping patients at the heart of NICE guidance development’.

Details on the speakers, plenary sessions, workshops and presentations can be found on the HTAi 2021 virtual annual meeting website.

Register to attend HTAi 2021


abstract image of a mobile phone with a heart inside it

Digital health technologies: an increased focus for NICE

Mark Salmon, programme director for information resources at NICE, reveals 2 exciting developments which will accelerate our efforts to deliver innovation to the health and care system.

Get involved

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for a finance representative to join our:

See all our committee vacancies

Observe a meeting

Due to the pandemic, we're holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Wednesday 8 and Thursday 9 June 2021 – Public health advisory committee C meeting
    • Social, emotional and mental health wellbeing
    Registration closes Wednesday 2 June 2021.
    Agenda and register
  • Tuesday 15 June 2021 – Diagnostics advisory committee meeting
    • Assessment of SeHCAT (tauroselcholic acid) for the investigation of bile acid diarrhoea
    Registration closes Tuesday 8 June 2021.
    Agenda and register
  • Wednesday 16 June 2021 – Quality standards advisory committee 3 meeting
    • Brain tumours (primary) and brain metastases in adults
    Registration closes Wednesday 9 June 2021.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings

unsubscribe from this list